Abbott Laboratories
| Name | Area | Department | Start Year | Stop Year | Advisor |
|---|---|---|---|---|---|
| Janel M. Boyce-Rustay | Behavioral Pharmacology | ||||
| Ana Maria Basso | Behavioral Neuroscience | ||||
| Lynne E. Rueter | depression, schizophrenia, learning/memory | ||||
| Kathy Chu | Neurophysiology | ||||
| Mike Jarvis | |||||
| Raymond Wieboldt | |||||
| Donald J. Osterling | Cerebral Ischemia | ||||
| Jack A. Grebb | Schizophrenia, substance abuse and signal transduction | ||||
| Nathan R. Rustay | Cognition, Behavior | 1998 | 2004 | John C. Crabbe (grad student) | |
| Kaitlin E. Browman | 1998 | 2000 | John C. Crabbe (post-doc) | ||
| Klara Abravaya | 1998 | 1993 | Richard I. Morimoto (post-doc) | ||
| Michael E. Ballard | behavior, psychopharmacology, human neuroimaging, PET, fMRI, stimulants, cannabinoids, cognition, delay discounting, executive function, memory, emotional processing, working memory | 2003 | 2007 | Lynne E. Rueter (research scientist), Min Zhang (research scientist) | |
| Min Zhang | Neuroscience Drug Discovery | 2003 | Lynne E. Rueter (research scientist) |